Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Colgate-Palmolive CL in ... and homecare products that are sold in over 200 countries.

Lawsuits claim products mislead consumers about fluoride safety Fluoride ingestion risks highlighted in lawsuits Study links fluoride exposure to lower IQ in children Parents filed complaints on ...

New York-based Colgate-Palmolive Company (CL) is a global leader in the oral care hygiene market. It produces and distributions household, healthcare and personal care products. With a market cap ...

Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.

Harbor Capital Advisors Inc. boosted its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 5.3% in the 4th ...

Piper Sandler analyst Korinne Wolfmeyer maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today. The company’s shares opened ...